This recall, labelled as a “class II” by the FDA, indicates that use of the affected product may result in temporary or reversible health consequences. The FDA encourages healthcare professionals to inform patients about alternative treatments and for pharmacists to dispense unaffected lots where possible. The agency has noted that nitrosamine impurities have been the cause of several recent drug recalls.